agilon health, inc. Profile Avatar - Palmy Investing

agilon health, inc.

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members…
Medical - Care Facilities
US, Austin [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 6688.60 2143.94 -31.58
Graham Fair Price -87.68 0.50 4.06
PEG -14926.82 -2.18 -0.01
Price/Book -55.05 3.46 7.71
Price/Cash Flow 42.53 -38.30 -66.64
Prices/Earnings 3072.24 221.21 -6.97
Price/Sales -69.18 1.49 4.83
Price/FCF 42.53 -38.30 -66.64
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -54.24 0.04 -0.09
Operating Margin 98.09 < 0.005 -0.16
ROA -98.89 < 0.005 -0.11
ROE -0.28 < 0.005 -98.58
ROIC -0.23 < 0.005 97.08
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.08 0.01 678.13
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -2.36 0.97 -58.77
EPS QOQ -4.81 1.01 -78.89
FCF QOQ -3.07 0.19 -93.96
Revenue QOQ -0.13 0.52 295.48
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 80.32 88.14 9.74
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.06 0.05 -12.73
Quick Ratio 1.47 1.31 -11.08
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 1.63 1.69 3.52
Cash 1.22 1.04 -14.49
Capex -0.04 -0.04 5.80
Free Cash Flow -0.19 -0.15 19.03
Revenue 2.60 3.92 51.00
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.51 1.33 -11.92
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 0.39 -65.31 16702.34
Naive Interpretation Member
06 - Financial Health · Weak
End of AGL's Analysis
CIK: 1831097 CUSIP: 00857U107 ISIN: US00857U1079 LEI: - UEI: -
Secondary Listings
AGL has no secondary listings inside our databases.